King Resources Global, Inc.: a fully owned subsidiary of King Resources Global, Inc., (the “KRFG”, “Company”, “we” or

King Resources Global, Inc. filed a Form 8-K on Monday, 9 November 2026: a fully owned subsidiary of King Resources Global, Inc., (the “KRFG”, “Company”

Published on by

King Resources Global, Inc. filed a Form 8-K at 13:12 UTC on Monday, 9 November 2026. a fully owned subsidiary of King Resources Global, Inc., (the “KRFG”, “Company”, “we” or “us”), entered into a Purchase Agreement (the “Purchase Agreement 1”) on November 5, 2026 with Grand View Assets Limited, a Hong Kong limited liability company (the “Seller 1”), pursuant to which the Buyer will purchase Six (6) pieces of collectible items (the “Collectibles 1”) from the Seller at the total amount of US$4,221,908.

In connection with the Purchase Agreement 2, the Buyer will settle the considerations by common stock of KRFG at the price of $0

Form 8-K is the current report that U.S. public companies file with the SEC to disclose significant events between their regular reports. This filing reports Item 1.01 (Entry into a Material Definitive Agreement) and Item 9.01 (Financial Statements and Exhibits).

Source: U.S. Securities and Exchange Commission (EDGAR) filing

More on this Story & Related In-Depth Reports

Markets & Finance

Newell Brands Inc.: the Board of Directors (the “Board”) of Newell Brands Inc. (the “Company”) voted to increase the

Newell Brands Inc. filed a Form 8-K at 13:35 UTC on Monday, 9 November 2026....

Markets & Finance

Fervo Energy Co reports third-quarter 2026 Ended Q3 2026 with unrestricted cash and cash equivalents of $1.9 billion

Fervo Energy Company, global pioneer of next-generation geothermal energy, today reported financial and operational resu...

Markets & Finance

Sonoco Products Company: Chief Executive Officer Transition On November 6, 2026, R. Howard Coker, Director, President

Sonoco Products Company filed a Form 8-K at 13:38 UTC on Monday, 9 November 2026....

Markets & Finance

Whitehawk Therapeutics, Inc. (the " Company ") issued a press release announcing its financial results for the quarter

Whitehawk Therapeutics, Inc. filed a Form 8-K at 13:04 UTC on Monday, 9 November 2026....